Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome

MAJEK, P.^G; SOVOVA, Z.; PECANKOVA, K.; CERMAK, J.; GASOVA, Z.; PECHERKOVA, P.; IGNJATOVIC, V.; DYR, J.E. Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome. Cancer biomarkers. 2022, vol. 34, no. 3, s. 485-492. ISSN 1574-0153. SJR: 0.622, rok: 2022; Cite Score: 6.100, rok: 2022; IF: 3.100, rok: 2022.